0001654954-21-011412.txt : 20211027
0001654954-21-011412.hdr.sgml : 20211027
20211027162231
ACCESSION NUMBER: 0001654954-21-011412
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211026
FILED AS OF DATE: 20211027
DATE AS OF CHANGE: 20211027
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fleming Zachary B.
CENTRAL INDEX KEY: 0001799602
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39678
FILM NUMBER: 211353065
MAIL ADDRESS:
STREET 1: 1200 SUMMIT AVE
STREET 2: SUITE 414
CITY: FORT WORTH
STATE: TX
ZIP: 76102
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sanara MedTech Inc.
CENTRAL INDEX KEY: 0000714256
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 592220004
STATE OF INCORPORATION: TX
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1200 SUMMIT AVE
STREET 2: SUITE 414
CITY: FORT WORTH
STATE: TX
ZIP: 76102
BUSINESS PHONE: 817-529-2300
MAIL ADDRESS:
STREET 1: 1200 SUMMIT AVE
STREET 2: SUITE 414
CITY: FORT WORTH
STATE: TX
ZIP: 76102
FORMER COMPANY:
FORMER CONFORMED NAME: WOUND MANAGEMENT TECHNOLOGIES, INC.
DATE OF NAME CHANGE: 20080611
FORMER COMPANY:
FORMER CONFORMED NAME: MB SOFTWARE CORP
DATE OF NAME CHANGE: 19960805
FORMER COMPANY:
FORMER CONFORMED NAME: INAV TRAVEL CORPORATION
DATE OF NAME CHANGE: 19920703
4
1
section16.xml
PRIMARY DOCUMENT
X0306
4
2021-10-26
0000714256
Sanara MedTech Inc.
SMTI
0001799602
Fleming Zachary B.
1200 SUMMIT AVE
SUITE 414
FORT WORTH
TX
76102
true
President - Surgical Div.
Common Stock
2021-10-26
4
S
false
1000
34.04
D
17708
D
The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2021.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.89 to $34.25, inclusive. The reporting person undertakes to provide to Sanara MedTech Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
/s/ Zachary B. Fleming
2021-10-27